Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medicover AB ( ($SE:MCOV.B) ) has shared an update.
Medicover AB has announced the composition of its nomination committee for the 2026 Annual General Meeting, which includes representatives from Celox Holding AB, NG Invest Beta AB, Fjärde AP-Fonden, and Swedbank Robur Fonder. This announcement is significant as it sets the stage for shareholder engagement and governance planning ahead of the AGM scheduled for April 2026.
The most recent analyst rating on ($SE:MCOV.B) stock is a Hold with a SEK265.00 price target. To see the full list of analyst forecasts on Medicover AB stock, see the SE:MCOV.B Stock Forecast page.
More about Medicover AB
Medicover is a leading international healthcare and diagnostic services company founded in 1995. It operates numerous ambulatory clinics, hospitals, laboratories, and specialty-care facilities, with major markets in Poland, Germany, Romania, and India. In 2024, Medicover reported a revenue of EUR 2,092 million and employed over 47,000 people.
Average Trading Volume: 76,405
Technical Sentiment Signal: Buy
Current Market Cap: SEK38.58B
See more insights into MCOV.B stock on TipRanks’ Stock Analysis page.